The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...

Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without ...

Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and operational framework essential for a study's success. Crafting, reviewing, and ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology ...

This article was paid for by Pfizer and provided by the Pfizer Multicultural Health Equity Collective in collaboration with UnidosUS. The views expressed are theirs alone. This article has not been ...